Senate Bill Would Prevent Safety Label Carve-Outs From Delaying Approvals
Updated drug pricing bill would allow US FDA to approve generics even if innovator safety information is protected by exclusivity.
Updated drug pricing bill would allow US FDA to approve generics even if innovator safety information is protected by exclusivity.